Rwanda vs Sweden: Access to anti-retroviral drugs, female
Rwanda
97.0%
in 2024
Sweden
96.0%
in 2022
Rwanda rank
12th
Sweden rank
14th
Access to anti-retroviral drugs, female over time
- Rwanda
- Sweden
How they compare
Rwanda currently reports 97.0% against 96.0% in Sweden, a difference of 1.0%.
Across all 23 years both countries report, Sweden has been ahead every year.
Rwanda ranks 12th and Sweden ranks 14th of 141 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.1% | 41.9% | 30.8% | Sweden |
| 2010s | 63.3% | 89.5% | 26.2% | Sweden |
| 2020s | 88.0% | 95.7% | 7.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Rwanda or Sweden?
- Rwanda, at 97.0% against 96.0% in Sweden as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Rwanda and Sweden?
- 1.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Rwanda and Sweden rank globally for access to anti-retroviral drugs, female?
- Rwanda ranks 12th and Sweden ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.